Skip to content
Governance Register

← US public companies

Kinnate Biopharma Inc.

SEC CIK 1797768 · KNTE · last insider filing 2024-04-05

Directors (from insider filings)

NameCapacity as filedFilings
Orbimed Advisors LLC Director filed 2020 - 2024
Orbimed Capital LLC Director filed 2020 - 2024
Mitchell Dean J Director filed 2020 - 2024
Gordon Carl L Director filed 2020 - 2024
Flaherty Keith T. Director filed 2020 - 2024
Tananbaum James B. Director filed 2020 - 2024
Smaldone Alsup Laurie Director filed 2020 - 2024
Sabzevari Helen Director filed 2021 - 2024
Orbimed Capital GP VII LLC Director filed 2020 - 2024
Epperly Melissa B, Director filed 2020 - 2024
Farzan Nima Director · President and CEO filed 2020 - 2024
Orbimed Genesis GP LLC Director filed 2020 - 2024
Rome Michael E Director filed 2020 - 2024
Orbimed Capital GP Viii LLC Director filed 2023 - 2024
Desimone Jill Director filed 2023 - 2024
Orbimed Advisors IV Ltd Director filed 2023 - 2024
Orbimed Asia GP IV, L.P. Director filed 2023 - 2024
Kaldor Stephen W Director filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Meltz Mark A COO General Counsel Treasurer filed 2020 - 2024
Krishnamohan Neha Chief Financial Officer filed 2021 - 2024
Williams Richard Thomas Chief Medical Officer filed 2020 - 2024
Murphy Eric Anthony Chief Scientific Officer filed 2020 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.